Presence and removal of arteriovenous malformation: Impact of regional cerebral blood flow, as assessed with xenon/CT

Acta Neurol Scand Suppl. 1996:166:136-8. doi: 10.1111/j.1600-0404.1996.tb00578.x.

Abstract

In 26 patients with supratentorial AVMs and 1 patient with a dural arteriovenous fistula, the regional cerebral blood flow (rCBF) was assessed by means of xenon-enhanced computed tomography (Xe/CT) before and after complete resective surgery. Each assessment comprised an acetazolamide challenge in order to check the cerebrovascular reserve capacity. While scanning through the AVM was purposely avoided, a single brain slice at the level of the basal ganglia was examined. Five regions of interest (ROIs) in gray matter of the AVM-bearing hemisphere were compared to the contralateral ROIs and categorized into 7 CBF groups. Interhemispherical differences exceeding 20% of the contralateral value in either direction were considered to the significant. AVM-related (AVM-R) and AVM-non-related (AVM-NR) ROIs were looked at separately. Before surgery, all possible rCBF patterns were found, including a normal rCBF as well as a reduced or an increased rCBF, either in AVM-R, AVM-NR, or both. After AVM removal, a rCBF increase in AVM-R is relatively rare, whereas a rCBF decrease is twice as frequent. A rCBF drop to a level of impaired reserve capacity correlates with the occurrence of post-operative neurological deficit.

MeSH terms

  • Acetazolamide
  • Adolescent
  • Adult
  • Blood Flow Velocity / physiology
  • Brain / blood supply*
  • Brain Ischemia / physiopathology*
  • Brain Ischemia / surgery
  • Contrast Media*
  • Dominance, Cerebral / physiology
  • Female
  • Humans
  • Intracranial Arteriovenous Malformations / physiopathology*
  • Intracranial Arteriovenous Malformations / surgery
  • Male
  • Middle Aged
  • Postoperative Complications / diagnosis
  • Postoperative Complications / physiopathology*
  • Regional Blood Flow / physiology
  • Tomography, X-Ray Computed*
  • Xenon*

Substances

  • Contrast Media
  • Xenon
  • Acetazolamide